Passio Human Microbiomesp. z o.o.
Research and experimental development on biotechnology
Overview
Passio Human Microbiome is a biotechnology company conducting research and implementation in the field of microbiome modulation. It focuses on mapping the gut microbiome, determining its role in energy and drug delivery, and developing new therapies for oncology, gastroenterology, and diabetology. The company also studies the impact of the microbiome on metabolic health and its potential in supporting treatments for various diseases.
Financials
The financial statement for 2020 has not yet been filed with the Financial Document Repository (past deadline).
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2019.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2019-06-28. Active
04 1090 1072 0000 0001 3375 0147
Debt
11 closed proceedings recorded in KRZ history. Closed proceedings in history
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Jun 24, 2024 | Discontinued enforcement proceedings | Closed | |
| Jun 24, 2024 | Discontinued enforcement proceedings | Closed | |
| Jun 24, 2024 | Discontinued enforcement proceedings | Closed | |
| Jun 24, 2024 | Discontinued enforcement proceedings | Closed | |
| Jun 24, 2024 | Discontinued enforcement proceedings | Closed |
Public aid
9 public aid cases recorded, with a total value of $13,269.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 23, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282 | PREZYDENT MIASTA BYDGOSZCZ | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $3,080 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $3,080 | Prezes Zakładu Ubezpieczeń Społecznych |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Emil Łukasz Klucz (47) | 10,800 | $291,734.20 | 60% |
Małgorzata Smorąg Różycka (64) | 3,600 | $97,244.73 | 20% |
Marek Aleksander Tiahnybok (57) | 3,600 | $97,244.73 | 20% |
Beneficial owners
| Person | Rights |
|---|---|
Emil Łukasz Klucz (47) | Shareholder of a limited liability company, 1079900.0 PLN |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Micropurasp. z o.o. | $12,556.50 | micropura.eu | |
| InventroS.A. | $12,176.61 | inventro.co | |
| Detoxedsp. z o.o. | $11,972.37 | detoxed.pl | |
| Oncotherics PolandS.A. | $7,565.33 | oncotherics.com | |
| Microbiota Medsp. z o.o. | $7,423.69 | microbiota-med.com | |
| Jotachemsp. z o.o. | $6,512.58 | jotachem.pl | |
| KMJsp. z o.o. | $5,565.54 | kmj24.pl | |
| Poltisssp. z o.o. | $3,843.72 | poltiss.com | |
| Omnisepticasp. z o.o. | $3,475.29 | omniseptica.com |
Change history
| Date | Event |
|---|---|
| 2022-03-31 | Address change (Ul. Bydgoskich Przemysłowców 6, 85-862, Bydgoszcz → Ul. Wojska Polskiego 65 A/215, 85-825, Bydgoszcz) |
| 2019-05-08 | Share capital change (1,600,000.00 PLN → 1,800,000.00 PLN) |
| 2018-09-24 | Share capital change (1,000,000.00 PLN → 1,600,000.00 PLN) |
| 2018-04-26 | Share capital change (400,000.00 PLN → 1,000,000.00 PLN) |
| 2016-11-30 | Entered in the register |
FAQ
Last updated: 2026-04-20